Depo-Provera
Recent studies have linked Depo-Provera, a contraceptive manufactured by Pfizer, to higher risks of developing meningiomas, or brain tumors that are typically benign.
Despite usually not being cancerous, meningiomas can cause disruptive symptoms, grow to become life-threatening, and may require risky or invasive surgery to remove.
If you’ve developed a brain tumor after long-term use of Depo-Provera, you may be eligible to file a lawsuit. Call 1-800-LAW-FIRM or fill out the following form for a free consultation.
Depo-Provera Lawsuit Update (November 2026)
- Thousands of cases are in federal court. As of November 2, 2026, 6,413 lawsuits were pending in MDL No. 3140 in the Northern District of Florida before Judge M. Casey Rodgers.
- Most existing claims are settling. A settlement announced on June 15, 2026 is expected to resolve most of the claims in the MDL and in New York state court. The court estimated that about 80% of MDL plaintiffs are eligible. The terms are confidential, and this is not a class action.
- The settlement registration deadline is November 30, 2026. On October 29, 2026, the court approved the fund that will be used to pay settlements.
- The litigation continues for other cases. Cases that are not part of the settlement, including newly filed cases, continue in court under the judge’s case management orders.
- The FDA label now warns of meningioma. In December 2025, the FDA approved updated Depo-Provera labeling that warns about the risk of meningioma.
Last updated November 6, 2026. This update is general information, not legal advice.